| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 27.112 | 32.245 | 41.107 | 51.708 | 46.447 | 58.335 | 67.654 | 78.903 |
| Total Income - EUR | - | - | 27.112 | 57.602 | 63.216 | 63.716 | 56.408 | 84.943 | 70.575 | 103.114 |
| Total Expenses - EUR | - | - | 5.551 | 33.114 | 43.264 | 48.339 | 48.955 | 35.551 | 67.591 | 181.658 |
| Gross Profit/Loss - EUR | - | - | 21.561 | 24.488 | 19.952 | 15.377 | 7.452 | 49.391 | 2.985 | -78.544 |
| Net Profit/Loss - EUR | - | - | 20.748 | 24.095 | 19.541 | 14.880 | 5.794 | 47.737 | 2.410 | -80.674 |
| Employees | - | - | 0 | 2 | 2 | 2 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Atimob Terapia Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 28 | 59.273 | 55.143 | 44.059 | 41.301 | 94.456 | 276.505 | 362.301 |
| Current Assets | - | - | 65.000 | 10.258 | 21.466 | 23.237 | 21.216 | 43.848 | 226.423 | 7.814 |
| Inventories | - | - | 0 | 925 | 2.130 | 0 | 0 | 91 | 0 | 0 |
| Receivables | - | - | 45.183 | 5.474 | 4.135 | 6.073 | 3.756 | 5.970 | 214.123 | 1.253 |
| Cash | - | - | 19.817 | 3.860 | 15.200 | 17.164 | 17.460 | 37.787 | 12.300 | 6.560 |
| Shareholders Funds | - | - | 20.792 | 44.505 | 63.184 | 66.013 | 42.749 | 90.619 | 92.754 | 11.561 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 455 | 3.537 | 6.401 | 1.284 | 19.879 | 43.056 | 206.887 | 186.210 |
| Income in Advance | - | - | 43.782 | 21.489 | 7.024 | 0 | 0 | 5.949 | 210.538 | 174.832 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Atimob Terapia Srl